United States regulators have for the first time approved a drug that can slow the progression of Alzheimer's disease, the most common type of dementia, offering hope for the growing pool of such patients here as well.
Current medications are able to treat just the symptoms of Alzheimer's, a disease which robs patients of their memory and cognitive abilities as the cells in their brains that process, store and retrieve information degenerate and die.
Already a subscriber? Log in
Read the full story and more at $9.90/month
Get exclusive reports and insights with more than 500 subscriber-only articles every month
ST One Digital
$9.90/month
No contract
ST app access on 1 mobile device
Unlock these benefits
All subscriber-only content on ST app and straitstimes.com
Easy access any time via ST app on 1 mobile device
E-paper with 2-week archive so you won't miss out on content that matters to you